Expertise in
5
conditions

Hideki Tokunaga

Sendai, JP 
Expertise in
5
conditions
Sendai, JP 

Overview

Hideki Tokunaga practices practicing medicine in Sendai, Japan.

Mr. Tokunaga is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Hysterectomy, and Lymphadenectomy.

He is actively involved in clinical research, co-authoring 123 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Sendai, Japan
Other Locations
Japan
Tohoku, Japan
Yamagata, 9909585, Japan
Shinjuku, 1608582, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Cisplatin
Study Phase: Phase 3
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Enrollment Status: Unknown
Publish Date: May 03, 2024
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

123 Total Publications

Clinicopathological Status and Prognostic Factors of Recurrent Epithelial Ovarian Cancer in Japan: Retrospective Survey of JSOG Committee on Gynecologic Oncology.
Clinicopathological Status and Prognostic Factors of Recurrent Epithelial Ovarian Cancer in Japan: Retrospective Survey of JSOG Committee on Gynecologic Oncology.
Journal: The journal of obstetrics and gynaecology research
Published: February 09, 2026

Frequently Asked Questions about Hideki Tokunaga

Is Hideki Tokunaga a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Hideki Tokunaga is classified as an Distinguished expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hideki Tokunaga participate in research or clinical trials?

Yes. Hideki Tokunaga has published 123 articles and abstracts on conditions like Cervical Cancer. You can view a list of Hideki Tokunaga's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tokunaga's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile